Accelerating new knowledge in schizophrenia

American Journal of Psychiatry

Volumn 165, Issue 8, 2008, Pages 949-951

  Tamminga, Carol A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITIVE DEFECT; EDITORIAL; ELECTROENCEPHALOGRAM; HUMAN; NEUROIMAGING; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA;

BRAIN; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; SCHIZOPHRENIA;

EID: 48949099039     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2008.08060815     Document Type: Editorial

References (11)

1. Charney DS, Nestler EJ: Neurobiology of Mental Illness, 2nd ed. New York, Oxford University Press, 2005
2. Gründer G, Fellows C, Janouschek H, Veselinovic T, Boy C, Bröcheler A, Kirschbaum KM, Hellmann S, Spreckelmeyer KM, Hiemke C, Rösch F, Schaefer WM, Vernaleken I: Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study. Am J Psychiatry 2008; 165:988-995
3. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E: The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 2008; 165:1015-1023
4. Friedman JI, Tang C, Carpenter D, Buchsbaum M, Schmeidler J, Flanagan L, Golembo S, Kanellopoulou I, Ng J, Hof PR: Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. Am J Psychiatry 2008; 165:1024-1032
5. Ferrarelli F, Massimini M, Peterson MJ, Riedner BA, Lazar M, Murphy MJ, Huber R, Rosanova M, Alexander AL, Kalin N, Tononi G: Reduced evoked gamma oscillations in the frontal cortex in schizophrenia patients: a TMS/EEG study. Am J Psychiatry 2008; 165:996-1005
6. Yoon JH, Minzenberg MJ, Ursu S, Walters R, Wendelken C, Ragland JD, Carter CS: Association of dorsolateral prefrontal cortex dysfunction with disrupted coordinated brain activity in schizophrenia: relationship with impaired cognition, behavioral disorganization, and global function. Am J Psychiatry 2008; 165:1006-1014
7. Shekhar A, Potter WZ, Lightfoot J, Lienemann J, Dubé S, Mallinckrodt C, Bymaster FP, McKinzie DL, Felder CC: Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia. Am J Psychiatry 2008; 165:1033-1039
8. Freedman R, Olincy A, Buchanan RW, Harris JG, Gold JM, Johnson L, Allensworth D, Guzman-Bonilla A, Clement B, Ball MP, Kutnick J, Pender V, Martin LF, Stevens KE, Wagner BD, Zerbe GO, Soti F, Kem WR: Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am J Psychiatry 2008; 165:1040-1047
9. Mohamed S, Rosenheck R, Swartz M, Stroup S, Lieberman JA, Keefe RS: Relationship of cognition and psychopathology to functional impairment in schizophrenia. Am J Psychiatry 2008; 165:978-987
10. Ivleva E, Thaker G, Tamminga CA: Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder. Schizophr Bull 2008; 34:734-742
11. Hyman SE, Fenton WS: Medicine: what are the right targets for psychopharmacology? Science 2003; 299:350-351